Lab Information
Arielle Mendel (MD/MSc)
Junior ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Systemic autoimmune rheumatic diseases • systemic vasculitis • systemic lupus erythematosus • patient safety and quality improvement • medication safetyResearch Interests
My research focuses on patient safety in systemic autoimmune rheumatic disease. I aim to improve medication safety in this population by studying root causes of adverse drug events, with a particular focus on glucocorticoids (i.e., prednisone) and other immunosuppressive agents, in order to design innovative strategies for improving medication safety in this population.Team Members
| Name | Position |
|---|
Latest Publications
- Eder, L., Croxford, R., Drucker, A. M., Mendel, A., Kuriya, B., Touma, Z., Johnson, S. R., Cook, R., Bernatsky, S., Haroon, N. & Widdifield, J. (2022). COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls. The Journal of rheumatology, vol. 49, p. 523-530.
- Barber, C. E. H., Levy, D. M., Ahluwalia, V., Mendel, A., Taylor-Gjevre, R., Gerschman, T., Koppikar, S., Jilkine, K., Stringer, E., Barnabe, C., Aydin, S. Z., Luca, N., Berard, R., Tam, K., Burt, J., Murdoch, J. C., Zinck, G., Lane, T., Heeley, J., Mannerow, M., Mills, R., Wilhelm, L., Spencer, N. & Ohata, B. (2022). Best Practices for Virtual Care, a Consensus Statement from the Canadian Rheumatology Association. The Journal of rheumatology, vol. 49, p. 408-418.
- Eder, L., Croxford, R., Drucker, A. M., Mendel, A., Kuriya, B., Touma, Z., Johnson, S. R., Cook, R., Bernatsky, S., Haroon, N. & Widdifield, J. (2021). Understanding COVID-19 Risk in Patients with Immune Mediated Inflammatory Diseases: A Population-based analysis of SARS-CoV-2 Testing. Arthritis care & research.
- Mendel, A. & Pagnoux, C. (2021). Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020. The Journal of rheumatology, vol. 48, p. 1755-1756.
- Mendel, A., Ennis, D., Lake, S., Carette, S. & Pagnoux, C. (2021). An Initiative to Improve Timely Glucocorticoid Tapering in Vasculitis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol. 27, p. e612-e615.
- Mendel, A., Ennis, D., Carette, S. & Pagnoux, C. (2020). Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides. Clinical and experimental rheumatology, vol. 39 Suppl 129, p. 119-124.
- Mendel, A., Ennis, D., Go, E., Bakowsky, V., Baldwin, C., Benseler, S. M., Cabral, D. A., Carette, S., Clements-Baker, M., Clifford, A. H., Cohen Tervaert, J. W., Cox, G., Dehghan, N., Dipchand, C., Dhindsa, N., Famorca, L., Fifi-Mah, A., Garner, S., Girard, L.-P., Lessard, C., Liang, P., Noone, D., Makhzoum, J.-P., Milman, N., Pineau, C. A., Reich, H. N., Rhéaume, M., Robinson, D. B., Rumsey, D. G., Towheed, T. E., Trudeau, J., Twilt, M., Yacyshyn, E., Yeung, R. S. M., Barra, L. B., Khalidi, N. & Pagnoux, C. (2021). CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. The Journal of rheumatology, vol. 48, p. 555-566.
- Mendel, A., Bernatsky, S., Askanase, A., Bae, S.-C., Clarke, A. E., Costedoat-Chalumeau, N., Gladman, D. D., Gordon, C., Hanly, J., Jacobsen, S., Kalunian, K., Mak, A., Mosca, M., Pons-Estel, B. A., Ruiz-Irastorza, G., Urowitz, M. & Vinet, É. (2021). Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics. Annals of the rheumatic diseases, vol. 80, p. 1-2.
- Mendel, A., Bernatsky, S., Thorne, J. C., Lacaille, D., Johnson, S. R. & Vinet, É. (2020). Hydroxychloroquine shortages during the COVID-19 pandemic. Annals of the rheumatic diseases.
- Mendel, A., Bernatsky, S., Pineau, C. A., St-Pierre, Y., Hanly, J. G., Urowitz, M. B., Clarke, A. E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D. J., Merrill, J. T., Buyon, J., Isenberg, D. A., Rahman, A., Ginzler, E. M., Petri, M., Dooley, M. A., Fortin, P., Gladman, D. D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M. A., Aranow, C., Mackay, M., Alarcón, G., Manzi, S., Nived, O., Jönsen, A., Zoma, A. A., van Vollenhoven, R. F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K. C., Inanc, M., Kamen, D. L., Peschken, C. A., Jacobsen, S., Askanase, A., Sanchez-Guerrero, J., Bruce, I. N., Costedoat-Chalumeau, N. & Vinet, E. (2019). Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford, England), vol. 58, p. 1259-1267.
